| Hans-Günter Meyer-Thompson | Buprenorphin
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
Andorn AC, Haight BR, Shinde S, Fudala PJ, Zhao Y, Heidbreder C, Learned SM, Fox NL, Nadipelli VR, Hassman D, Rutrick D.
J Clin Psychopharmacol. 2020 Apr 9. doi: 10.1097/JCP.0000000000001195.
Download -> PDF -> open access
https://journals.lww.com/psychopharmacology/Abstract/9000/Treating_Opioid_Use_Disorder_With_a_Monthly.98443.aspx